Zydus Lifesciences gets warning letter from USFDA for Jarod facility

30 Aug 2024 Evaluate

Zydus Lifesciences has received a Warning Letter from the USFDA relating to its Injectables manufacturing facility at Jarod near Vadodara. The Warning Letter summarizes violations with respect to Current Good Manufacturing Practice (cGMP) regulations. The Warning Letter does not contain any data integrity related violations. 

Earlier on July 18, 2024, the company’s Jarod facility had received official action indicated (OAI) status by the USFDA . This site was inspected by USFDA from April 15 to April 23, 2024. The contents of the Warning Letter will be made public by the USFDA in due course.

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.


Zydus Lifesciences Share Price

912.90 -1.75 (-0.19%)
01-Jan-2026 13:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.95
Dr. Reddys Lab 1249.95
Cipla 1499.90
Zydus Lifesciences 912.90
Lupin 2099.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×